91 related articles for article (PubMed ID: 23643861)
1. Cloning and characterization of a novel human BRMS1 transcript variant in hepatocellular carcinoma cells.
Wu J; Wang Y; Qiao X; Saiyin H; Zhao S; Qiao S; Wu Y
Cancer Lett; 2013 Sep; 337(2):266-75. PubMed ID: 23643861
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression.
Wu Y; Jiang W; Wang Y; Wu J; Saiyin H; Qiao X; Mei X; Guo B; Fang X; Zhang L; Lou H; Wu C; Qiao S
PLoS One; 2012; 7(8):e42976. PubMed ID: 22927944
[TBL] [Abstract][Full Text] [Related]
4. Characterization of DAPK1 as a novel transcriptional target of BRMS1.
Qiao X; Yang X; Zhou Y; Mei X; Dou J; Xie W; Li G; Wang Y; Qiao S; Hu J; Wu Y
Int J Oncol; 2017 May; 50(5):1760-1766. PubMed ID: 28339067
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.
Sato Y; Kato J; Takimoto R; Takada K; Kawano Y; Miyanishi K; Kobune M; Sato Y; Takayama T; Matunaga T; Niitsu Y
Gut; 2006 Dec; 55(12):1801-8. PubMed ID: 16581947
[TBL] [Abstract][Full Text] [Related]
6. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
Zhang P; Chan DW; Zhu Y; Li JJ; Ng IO; Wan D; Gu J
Clin Cancer Res; 2006 Nov; 12(22):6617-25. PubMed ID: 17121880
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
8. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.
Lu X; Feng X; Man X; Yang G; Tang L; Du D; Zhang F; Yuan H; Huang Q; Zhang Z; Liu Y; Strand D; Chen Z
Clin Cancer Res; 2009 May; 15(10):3287-96. PubMed ID: 19447873
[TBL] [Abstract][Full Text] [Related]
9. FUP1, a gene associated with hepatocellular carcinoma, stimulates NIH3T3 cell proliferation and tumor formation in nude mice.
Pan W; Zhang Q; Xi QS; Gan RB; Li TP
Biochem Biophys Res Commun; 2001 Sep; 286(5):1033-8. PubMed ID: 11527404
[TBL] [Abstract][Full Text] [Related]
10. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
[TBL] [Abstract][Full Text] [Related]
11. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
12. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma.
Zhao X; Li J; He Y; Lan F; Fu L; Guo J; Zhao R; Ye Y; He M; Chong W; Chen J; Zhang L; Yang N; Xu B; Wu M; Wan D; Gu J
Cancer Res; 2001 Oct; 61(20):7383-7. PubMed ID: 11606366
[TBL] [Abstract][Full Text] [Related]
13. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
Samant RS; Debies MT; Hurst DR; Moore BP; Shevde LA; Welch DR
Cancer Lett; 2006 Apr; 235(2):260-5. PubMed ID: 15978719
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo].
Jiang J; Xia M; Feng JB; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):398-402. PubMed ID: 17697602
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R
Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745
[TBL] [Abstract][Full Text] [Related]
19. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
[TBL] [Abstract][Full Text] [Related]
20. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]